PubMed for Bookshelf ID: 4840264

Year	Number of Results
2009	1
2011	1
2012	3
2013	1
2015	5
2016	5
2017	11
2018	2
2024	0

1

Flibanserin for Hypoactive Sexual Desire Disorder: An Open-Label Safety Study.

Simon JA, Derogatis L, Portman D, Brown L, Yuan J, Kissling R. Simon JA, et al. J Sex Med. 2018 Mar;15(3):387-395. doi: 10.1016/j.jsxm.2017.12.016. J Sex Med. 2018. PMID: 29502984

2

Recommendations for Clinical CYP2C19 Genotyping Allele Selection: A Report of the Association for Molecular Pathology.

Pratt VM, Del Tredici AL, Hachad H, Ji Y, Kalman LV, Scott SA, Weck KE. Pratt VM, et al. J Mol Diagn. 2018 May;20(3):269-276. doi: 10.1016/j.jmoldx.2018.01.011. Epub 2018 Feb 21. J Mol Diagn. 2018. PMID: 29474986 Free article. Review.

3

Flibanserin: From Bench to Bedside.

Dooley EM, Miller MK, Clayton AH. Dooley EM, et al. Sex Med Rev. 2017 Oct;5(4):461-469. doi: 10.1016/j.sxmr.2017.06.003. Epub 2017 Jul 27. Sex Med Rev. 2017. PMID: 28757356 Free article. Review.

4

Flibanserin Efficacy and Safety in Premenopausal Women With Generalized Acquired Hypoactive Sexual Desire Disorder.

Fisher WA, Pyke RE. Fisher WA, et al. Sex Med Rev. 2017 Oct;5(4):445-460. doi: 10.1016/j.sxmr.2017.05.003. Epub 2017 Jun 27. Sex Med Rev. 2017. PMID: 28666836 Free article. Review.

5

The pharmacodynamic effects of combined administration of flibanserin and alcohol.

Stevens DM, Weems JM, Brown L, Barbour KA, Stahl SM. Stevens DM, et al. J Clin Pharm Ther. 2017 Oct;42(5):598-606. doi: 10.1111/jcpt.12563. Epub 2017 Jun 13. J Clin Pharm Ther. 2017. PMID: 28608926 Clinical Trial.

6

Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder: Results of the PLUMERIA Study.

Portman DJ, Brown L, Yuan J, Kissling R, Kingsberg SA. Portman DJ, et al. J Sex Med. 2017 Jun;14(6):834-842. doi: 10.1016/j.jsxm.2017.03.258. J Sex Med. 2017. PMID: 28583342 Free article. Clinical Trial.

7

New developments in the treatment of hypoactive sexual desire disorder - a focus on Flibanserin.

Jayne CJ, Heard MJ, Zubair S, Johnson DL. Jayne CJ, et al. Int J Womens Health. 2017 Apr 10;9:171-178. doi: 10.2147/IJWH.S125356. eCollection 2017. Int J Womens Health. 2017. PMID: 28442935 Free PMC article. Review.

8

Flibanserin - the female Viagra?

Shapiro D, Stevens D, Stahl SM. Shapiro D, et al. Int J Psychiatry Clin Pract. 2017 Nov;21(4):259-265. doi: 10.1080/13651501.2017.1315138. Epub 2017 Apr 24. Int J Psychiatry Clin Pract. 2017. PMID: 28434386 Review.

9

Flibanserin (Addyi): The First FDA-Approved Treatment for Female Sexual Interest/Arousal Disorder in Premenopausal Women.

English C, Muhleisen A, Rey JA. English C, et al. P T. 2017 Apr;42(4):237-241. P T. 2017. PMID: 28381915 Free PMC article.

10

Flibanserin for hypoactive sexual desire disorder: place in therapy.

Gelman F, Atrio J. Gelman F, et al. Ther Adv Chronic Dis. 2017 Jan;8(1):16-25. doi: 10.1177/2040622316679933. Epub 2017 Jan 18. Ther Adv Chronic Dis. 2017. PMID: 28203348 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

24 results

Results by year